Shares of QTREX Quantum Ltd. slipped 6% to $2.82 on May 29, marking the first pullback after an extraordinary run that took the stock from $0.30 to $3.00 in just five trading days — a gain exceeding 840%. The catalyst: market speculation that the company is in advanced partnership talks with a top-five global quantum computing firm. For shareholders, the central question is whether this rally reflects genuine strategic value or the kind of speculative frenzy that routinely punishes latecomers. QTEX Rockets 840% in Five Days on Quantum Deal Hopes — Is This a Real Business Pivot or a Penny-Stock Mirage?
Shares of QTREX Quantum slid 6% to $2.82 on May 29, marking the first red day after an 840% sprint from $0.30 that turned an obscure micro-cap into the most-watched momentum ticker on Nasdaq. The trigger: the company announced it is in advanced discussions with one of the top five companies globally in quantum computing systems regarding a strategic collaboration agreement . Today's pullback looks like textbook profit-taking, but for anyone tempted to chase the next leg, the gap between the story and the fundamentals is enormous.
A Renamed Medical-Device Firm Betting Everything on Quantum Wiring
The company was formerly known as Inspira Technologies Oxy B.H.N. Ltd. and changed its name to QTREX Quantum Ltd. in May 2026 . The rebranding reflects a strategic focus on additive manufacturing electronics and quantum connectivity infrastructure — specifically, building cryogenic wiring inside the ultra-cold refrigerators that quantum computers need to function. As of May 28, 2026, the company has 40 employees . That is the entire operation behind a stock that now commands a $92 million market cap.
The Revenue Says One Thing; the Stock Says Another
Recent revenue is about $289,000, while the market is assigning a price-to-sales ratio above 60 . Return on assets sits near −42% and return on equity around −59% . Net income for the last half-year was −$6.82 million . The entire rally rests on what the partnership might deliver: if a definitive agreement is signed, the partner could adopt QTREX's platform as its foundational cryogenic interconnect technology, embedding QTREX as a critical supplier across its future quantum hardware roadmap . No deal has been signed. No revenue timeline has been given.
A Real Problem Worth Solving — But the Stock Has Already Priced It In
As qubit counts grow, the bundle of hand-assembled coaxial cables inside a dilution refrigerator becomes a wall — more wires mean more heat, more noise, and more electromagnetic crosstalk, and as the field scales from hundreds of qubits to thousands, the cryostat becomes the central engineering constraint . The bottleneck is genuine. But that layer is dominated by private companies like Bluefors, Maybell Quantum, Delft Circuits, and Kiutra — well-funded competitors with deeper track records.
Dilution Risk Looms Behind the Hype
The company has an effective shelf registration allowing offerings of up to $75 million in ordinary shares, warrants, and units . As of June 30, 2025, it reported $2.1 million in cash with auditors including a going-concern paragraph, highlighting dependence on future financing . A stock trading at multiples this high with cash this low almost guarantees a share sale is coming — the only question is when and at what price.
Bottom line: QTEX solves a real quantum-hardware problem, but at $2.82 the stock has sprinted years ahead of any provable business. Traders should treat this as a sentiment vehicle, not an investment.